BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $119,572 | +166.1% | 24,156 | 0.0% | 0.00% | – |
| Q1 2023 | $44,930 | +3.9% | 24,156 | 0.0% | 0.00% | – |
| Q4 2022 | $43,240 | +5.5% | 24,156 | +0.0% | 0.00% | – |
| Q3 2022 | $41,000 | -35.9% | 24,145 | -7.3% | 0.00% | – |
| Q2 2022 | $64,000 | -11.1% | 26,036 | 0.0% | 0.00% | – |
| Q1 2022 | $72,000 | -49.7% | 26,036 | 0.0% | 0.00% | – |
| Q4 2021 | $143,000 | -47.8% | 26,036 | +205.7% | 0.00% | – |
| Q4 2020 | $274,000 | – | 8,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
| Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
| RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
| Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
| Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
| Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
| Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
| Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
| Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |